<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="e4eb4871-cf7f-4ed6-8937-aab454c47b8a"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — John Henry Holliday</title>
  <effectiveTime value="20260414120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="4c0b6a64-9ffb-42bc-96ff-20e9d523ff23"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="ba890b67-1c07-479c-a63c-0d60fb72dc7c" extension="HR-NI007-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-07-8153"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>John</given><given>Henry</given><family>Holliday</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="20040814"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260414120000-0500"/>
    <assignedAuthor><id root="9c232efd-83d3-4b12-ad6a-7db3e26dabfc"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Martin</given><family>Beaumont</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260414120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="9c232efd-83d3-4b12-ad6a-7db3e26dabfc"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Martin</given><family>Beaumont</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260414"/><high value="20260414"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="9c232efd-83d3-4b12-ad6a-7db3e26dabfc"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Martin</given><family>Beaumont</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="ae58deb4-b81f-41b3-b8e2-2c211cf02665"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>End of the intensive phase: two-month sputum and the start of the continuation phase</originalText></code>
      <effectiveTime><low value="20260414"/><high value="20260414"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="9c232efd-83d3-4b12-ad6a-7db3e26dabfc"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Martin</given><family>Beaumont</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>End of the intensive phase: two-month sputum and the start of the continuation phase. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Holliday returns after nine weeks of treatment. He completed the 56 doses of the intensive phase six days ago, and pyrazinamide was stopped; he now takes isoniazid, rifampin, and pyridoxine daily by video. The cultures from the third week show no growth so far, with the final reading due next week. His cough has gone, and he has gained weight. He has had no nausea, yellowing, dark urine, or numbness. He has had no alcohol for seven weeks and sees his counselor every two weeks. He is working full days. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Treatment</td><td>Intensive phase complete; continuation phase started six days ago</td></tr><tr><td>Symptoms</td><td>No cough, fever, or night sweats</td></tr><tr><td>Weight</td><td>62.5 kg, up 4.5 kg since diagnosis</td></tr><tr><td>Alcohol</td><td>None for seven weeks; AUDIT-C 1</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Respiratory</td><td>Negative</td><td>No cough, sputum, or blood</td></tr><tr><td>Constitutional</td><td>Negative</td><td>No fever or night sweats; appetite good</td></tr><tr><td>Gastrointestinal</td><td>Negative</td><td>No nausea or abdominal pain</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood good; no thoughts of suicide or self-harm</td></tr></tbody></table><paragraph>4 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Isoniazid 300 mg tablet, one tablet daily</td><td>300 mg once daily by video-observed therapy with the health department, seven days a week, for six months</td><td>Oral route</td><td>2026-02-12 to 2026-08-13</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Rifampin 300 mg capsules, two capsules (600 mg) daily</td><td>600 mg once daily on an empty stomach by video-observed therapy with the health department, seven days a week, for six months</td><td>Oral route</td><td>2026-02-12 to 2026-08-13</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Pyrazinamide 500 mg tablets, three tablets (1500 mg) daily</td><td>1500 mg once daily by video-observed therapy with the health department, seven days a week, for the eight-week intensive phase</td><td>Oral route</td><td>2026-02-12 to 2026-04-08</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Ethambutol 400 mg tablets, three tablets (1200 mg) daily</td><td>1200 mg once daily by video-observed therapy with the health department, seven days a week, until susceptibility results return</td><td>Oral route</td><td>2026-02-12 to 2026-03-10</td><td>stopped</td><td>S</td></tr><tr ID="medication-5"><td>Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily</td><td>50 mg once daily with isoniazid</td><td>Oral route</td><td>2026-02-12 to 2026-08-13</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="aace9dad-3eaa-4a98-9540-a888173fb9dd"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260212"/><high value="20260813"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="300" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197832" codeSystem="2.16.840.1.113883.6.88" displayName="isoniazid 300 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="46b92594-6225-45ec-a276-8aa9b5de96c9"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="f2bbcd18-7a6e-432f-b171-ae6b8e58d378"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260212"/><high value="20260813"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="600" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198202" codeSystem="2.16.840.1.113883.6.88" displayName="rifampin 300 MG Oral Capsule"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ff78e839-d6b4-4d07-ae2a-8a23edccc13f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="39b8c981-2c1d-44c0-9ec5-f19b5afb24f3"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260212"/><high value="20260408"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1500" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198181" codeSystem="2.16.840.1.113883.6.88" displayName="pyrazinamide 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ba09b452-30a6-4725-ada0-82d3ade0a90f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="81661edf-3007-4776-a3d6-70eceaaaf747"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260212"/><high value="20260310"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1200" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="995607" codeSystem="2.16.840.1.113883.6.88" displayName="ethambutol hydrochloride 400 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="b5ea5c69-7808-4f0b-8427-cd8bca4918cd"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="8f83ed2c-18ba-4119-9f20-c05992d57d31"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260212"/><high value="20260813"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="50" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="639566" codeSystem="2.16.840.1.113883.6.88" displayName="vitamin B6 50 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="b307879e-2cc3-4c78-91d1-6e4cdfbacbdb"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="c90937ab-e97b-486f-a1af-81e0c024b7a9"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="72f74a6c-6776-41d9-af4d-ee28e7320d9a"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-4-1"><td>2026-04-14</td><td>Body height</td><td>178</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-4-2"><td>2026-04-14</td><td>Body weight</td><td>62.5</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-4-3"><td>2026-04-14</td><td>Body mass index (BMI) [Ratio]</td><td>19.7</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-4-4"><td>2026-04-14</td><td>Systolic blood pressure</td><td>116</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-4-5"><td>2026-04-14</td><td>Diastolic blood pressure</td><td>74</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-4-6"><td>2026-04-14</td><td>Heart rate</td><td>78</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-4-7"><td>2026-04-14</td><td>Respiratory rate</td><td>16</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-4-8"><td>2026-04-14</td><td>Body temperature</td><td>36.7</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-4-9"><td>2026-04-14</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>98</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="00cb6b7f-a5fb-43ae-9313-415c8c4abe54"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260414"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a67ebae3-a797-4a6f-8e99-a2d05e89b9d4"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-4-1"/></text><statusCode code="completed"/><effectiveTime value="20260414"/><value xsi:type="PQ" value="178" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="60809b40-2ffa-463d-acd5-aaa205fc503c"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-4-2"/></text><statusCode code="completed"/><effectiveTime value="20260414"/><value xsi:type="PQ" value="62.5" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="027584db-bb60-4293-aaa0-07e89226799e"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-4-3"/></text><statusCode code="completed"/><effectiveTime value="20260414"/><value xsi:type="PQ" value="19.7" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="e5393c74-1d57-48a6-acf6-63dea658ef58"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-4-4"/></text><statusCode code="completed"/><effectiveTime value="20260414"/><value xsi:type="PQ" value="116" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a6fa9c8b-d5f9-4705-bb16-f6ef05769474"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-4-5"/></text><statusCode code="completed"/><effectiveTime value="20260414"/><value xsi:type="PQ" value="74" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5552843a-9cae-42b4-85ce-7a84405a6933"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-4-6"/></text><statusCode code="completed"/><effectiveTime value="20260414"/><value xsi:type="PQ" value="78" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="37f72dae-42f4-4541-95eb-29c2e791a937"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-4-7"/></text><statusCode code="completed"/><effectiveTime value="20260414"/><value xsi:type="PQ" value="16" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="0539e91f-2bcd-4d93-816a-f4a8707e94bd"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-4-8"/></text><statusCode code="completed"/><effectiveTime value="20260414"/><value xsi:type="PQ" value="36.7" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="63cc0265-b7c0-4d99-965b-9c2d72e6d547"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-4-9"/></text><statusCode code="completed"/><effectiveTime value="20260414"/><value xsi:type="PQ" value="98" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-29"><td>2026-04-14</td><td>Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>38</td><td>U/L</td><td>7-56 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-30"><td>2026-04-14</td><td>Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>35</td><td>U/L</td><td>10-40 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-31"><td>2026-04-14</td><td>Bilirubin.total [Mass/volume] in Serum or Plasma</td><td>0.7</td><td>mg/dL</td><td>0.1-1.2 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-32"><td>2026-04-14</td><td>Total score [AUDIT-C]</td><td>1</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="7637ec89-a069-499c-844a-68f292b8a239"/>
      <code code="1742-6" codeSystem="2.16.840.1.113883.6.1" displayName="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260414"/><high value="20260414"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="4c72651f-9929-4280-a3c2-ea35b17019b8"/>
          <code code="1742-6" codeSystem="2.16.840.1.113883.6.1" displayName="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-29"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260414"/>
          <value xsi:type="PQ" value="38" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>7-56 U/L</text>
              <value xsi:type="IVL_PQ"><low value="7" unit="U/L"/><high value="56" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="6c316e82-2a0d-45a8-9039-944cb3a00a54"/>
      <code code="1920-8" codeSystem="2.16.840.1.113883.6.1" displayName="Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260414"/><high value="20260414"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="228b5e03-4740-410d-a2da-5cfd84fec9f7"/>
          <code code="1920-8" codeSystem="2.16.840.1.113883.6.1" displayName="Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-30"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260414"/>
          <value xsi:type="PQ" value="35" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>10-40 U/L</text>
              <value xsi:type="IVL_PQ"><low value="10" unit="U/L"/><high value="40" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="fe584196-74dc-4e3c-b20f-f8b2c9723fdf"/>
      <code code="1975-2" codeSystem="2.16.840.1.113883.6.1" displayName="Bilirubin.total [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260414"/><high value="20260414"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="47694bfd-16b2-422f-b24c-bba2acc39768"/>
          <code code="1975-2" codeSystem="2.16.840.1.113883.6.1" displayName="Bilirubin.total [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-31"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260414"/>
          <value xsi:type="PQ" value="0.7" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.1-1.2 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.1" unit="mg/dL"/><high value="1.2" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="70c92aa2-b694-4771-931a-027516c0d2cb"/>
      <code code="75626-2" codeSystem="2.16.840.1.113883.6.1" displayName="Total score [AUDIT-C]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260414"/><high value="20260414"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="d27f8d19-46d9-4f82-a2f3-8d8d165025e0"/>
          <code code="75626-2" codeSystem="2.16.840.1.113883.6.1" displayName="Total score [AUDIT-C]"/>
          <text><reference value="#result-32"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260414"/>
          <value xsi:type="PQ" value="1" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-04-14; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; weight 62.5 kg</td></tr><tr><td>Eyes</td><td>No icterus</td></tr><tr><td>Respiratory</td><td>Clear apart from a few fine crackles at the right apex</td></tr><tr><td>Abdomen</td><td>Liver not enlarged or tender</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Pulmonary tuberculosis, right upper lobe cavitary, sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistance</td><td>active</td><td>confirmed</td>
    <td>A15.0</td><td>S — Synthetic modern coding of his documented pulmonary tuberculosis at the time of diagnosis; the bacteriology is synthetic.</td>
  </tr>
  <tr ID="problem-2">
    <td>Alcohol use disorder, mild, with binge drinking</td><td>active</td><td>confirmed</td>
    <td>F10.10</td><td>S — Synthetic modern coding anchored to the documented heavy drinking; the severity and the criteria met are synthetic.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="16d6981a-e081-41c4-aa55-92f247a1a745"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c3f312e6-fe20-4ff0-bfb6-ea1da5c6db20"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260210"/></effectiveTime>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="2d51467a-b0f4-42e4-8eb4-3790b22afc38"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="04782bc1-9e1c-4dd2-a26d-eea0ed5128ec"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260210"/></effectiveTime>
          <value xsi:type="CD" code="F10.10" codeSystem="2.16.840.1.113883.6.90" displayName="Alcohol abuse, uncomplicated"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Drug-susceptible pulmonary tuberculosis, continuation phase (A15.0)</content>. Intensive phase complete with full adherence and a good clinical response. Liver tests normal (ALT 38, AST 35, bilirubin 0.7). Because the disease was cavitary, the two-month culture taken today decides the length of the continuation phase: four months if negative, seven if positive. Dr. Navarro reviewed the plan by message today and agreed. [S]<list><item>Continue isoniazid 300 mg, rifampin 600 mg, and pyridoxine daily by video.</item><item>Sputum smear and culture today (induced, because he no longer coughs up sputum).</item><item>Monthly liver tests and symptom review continue.</item></list></item><item><content styleCode="Bold">Alcohol use disorder, mild (F10.10)</content>. No alcohol for seven weeks. Safety reviewed: no thoughts of suicide. [S]<list><item>Continue counseling every two weeks.</item><item>Plan ahead for social events where he used to drink.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Examination</td><td>Symptom review: cough, sputum, hemoptysis, fever, night sweats</td><td>At least monthly during treatment</td><td>Completed today</td><td>No symptoms</td></tr><tr><td>Examination</td><td>Weight</td><td>At least monthly during treatment</td><td>Completed today</td><td>62.5 kg</td></tr><tr><td>Medication safety</td><td>Hepatitis symptom review (nausea, vomiting, abdominal pain, jaundice, dark urine)</td><td>Every visit and every observed dose</td><td>Completed today</td><td>None</td></tr><tr><td>Laboratory</td><td>Liver tests (ALT, AST, bilirubin)</td><td>Baseline, at two weeks, then monthly because of alcohol use</td><td>Completed today</td><td>ALT 38, AST 35 U/L, bilirubin 0.7 mg/dL, all normal</td></tr><tr><td>Laboratory</td><td>Two-month sputum culture</td><td>At the end of the intensive phase; decides the continuation length in cavitary disease</td><td>Completed today</td><td>Induced sputum smear negative today; culture sent, final reading in six weeks</td></tr><tr><td>Laboratory</td><td>Sputum AFB smear and culture</td><td>Monthly until two consecutive cultures are negative</td><td>Completed today</td><td>Third-week cultures show no growth so far; final next week</td></tr><tr><td>Imaging</td><td>Chest X-ray</td><td>At diagnosis; at two months only if the first cultures were negative; at the end of treatment as a new baseline</td><td>Not indicated</td><td>Not needed at two months, because the first cultures were positive</td></tr><tr><td>Medication safety</td><td>Doses observed and missed (video-observed therapy)</td><td>Every visit</td><td>Completed today</td><td>All 56 intensive-phase doses observed</td></tr><tr><td>Medication safety</td><td>Peripheral neuropathy check, with pyridoxine</td><td>Every visit</td><td>Completed today</td><td>No neuropathy</td></tr><tr><td>Referral</td><td>Contact investigation (household, coworkers, patients)</td><td>Led by the health department, from diagnosis</td><td>Referred</td><td>Health department continuing; no results are part of his record</td></tr><tr><td>Survey</td><td>Alcohol use (AUDIT-C for the past month)</td><td>Every visit</td><td>Completed today</td><td>AUDIT-C 1 for the past month</td></tr><tr><td>Self-management</td><td>Brief counseling about alcohol and liver risk</td><td>Every visit</td><td>Completed today</td><td>Social events planned for</td></tr><tr><td>Referral</td><td>Counseling with a substance-use counselor</td><td>Every one to two weeks during treatment</td><td>Completed today</td><td>Every two weeks</td></tr><tr><td>Survey</td><td>Suicide-risk review and safety plan, with the 988 Suicide &amp; Crisis Lifeline</td><td>Every visit</td><td>Completed today</td><td>No thoughts of suicide</td></tr><tr><td>Referral</td><td>Infectious diseases review</td><td>At two months and at the end of treatment</td><td>Completed today</td><td>Dr. Navarro reviewed the plan by message today</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Complete 182 doses of treatment under video-observed therapy within six months. In progress; target 2026-08-18 [S]</item><item>Sputum culture negative at two months. In progress; target 2026-08-18 [S]</item><item>No alcohol during treatment, to protect his liver. In progress; target 2026-08-18 [S]</item><item>Return to work once he is no longer infectious. Outcome by 2026-03-17: Released from home isolation after three negative sputum smears and back at work four weeks into treatment [S]</item><item>Weight back to at least 64 kg by the end of treatment. In progress; target 2026-08-18 [S]</item></list><paragraph>Guideline basis: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); An official ATS statement: hepatotoxicity of antituberculosis therapy (2006); Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC (2005); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)</paragraph><paragraph>Follow-up: End-of-treatment visit after the last dose. Monthly liver tests and symptom review in between. Call the same day for hepatitis symptoms or a returning cough. Next scheduled visit 2026-08-18: end-of-treatment review after six months. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
